A method for screening positive single B cells that secrete target substances and a method for preparing monoclonal antibodies.

By using the Beacon single-cell photoconductive system to screen positive single B cells that secrete target substances, combined with reverse transcription, PCR amplification, and eukaryotic system expression, the shortcomings of traditional antibody discovery technologies have been overcome, enabling the preparation of high-throughput, high-purity FYL rabbit monoclonal antibodies, providing technical support for the development of a rapid fentanyl detection kit.

CN120971725BActive Publication Date: 2026-06-30ZHEJIANG LONGI BIOTECHNOLOGY CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202511020782.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-07-24
Publication Date
2026-06-30
Estimated Expiration
2045-07-24

Smart Images

  • Figure CN120971725B_ABST
    Figure CN120971725B_ABST
Patent Text Reader

Abstract

This invention relates to the field of biotechnology and provides a method for screening positive single B cells that secrete target substances and a method for preparing monoclonal antibodies. The positive single B cell screening method includes the following steps: isolating PBMCs from the peripheral blood of immunized animals; sorting memory B cells using magnetic beads and separation antibodies; activating and culturing memory B cells in vitro using an activation medium; and loading, analyzing, and exporting target positive cells from the activated memory B cells using a Beacon single-cell photoconductive system. This invention achieves high-throughput screening of FYL positive single B cells through the Beacon single-cell photoconductive system. Gene products are obtained through reverse transcription and PCR amplification, and accurate sequences are obtained through sequence analysis. The synthesized plasmid is expressed in a eukaryotic system, and high-purity FYL rabbit monoclonal antibodies are obtained through affinity chromatography, laying the foundation for the development of a rapid fentanyl detection kit.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Preparation process of fentanyl monoclonal antibody

    CN117551203A

  • Methods of producing high affinity antibodies against fentanyl

    CN118829658A

  • Hybrid creatine kinase isoenzyme double-antibody sandwich ELISA kit and preparation method thereof

    CN119510759A